PortfoliosLab logoPortfoliosLab logo
LMT vs. MRK
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

LMT vs. MRK - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Lockheed Martin Corporation (LMT) and Merck & Co., Inc. (MRK). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, LMT achieves a 9.57% return, which is significantly lower than MRK's 15.60% return. Over the past 10 years, LMT has underperformed MRK with an annualized return of 11.04%, while MRK has yielded a comparatively higher 11.69% annualized return.


LMT

1D
0.91%
1M
2.51%
YTD
9.57%
6M
17.20%
1Y
12.52%
3Y*
7.37%
5Y*
8.75%
10Y*
11.04%

MRK

1D
0.44%
1M
6.37%
YTD
15.60%
6M
23.07%
1Y
61.27%
3Y*
6.37%
5Y*
13.79%
10Y*
11.69%
*Multi-year figures are annualized to reflect compound growth (CAGR)

LMT vs. MRK - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
LMT
Lockheed Martin Corporation
9.57%2.47%10.02%-4.31%40.48%3.15%-6.49%52.55%-16.35%31.77%
MRK
Merck & Co., Inc.
15.60%9.79%-6.26%1.01%49.42%1.75%-7.20%22.27%39.95%-1.49%

Correlation

The correlation between LMT and MRK is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.16

Correlation (3Y)
Calculated over the trailing 3-year period

0.18

Correlation (5Y)
Calculated over the trailing 5-year period

0.20

Correlation (10Y)
Calculated over the trailing 10-year period

0.25

Correlation (All Time)
Calculated using the full available price history since Jan 16, 1978

0.26

Fundamentals

Market Cap

LMT:

$121.04B

MRK:

$298.59B

EPS

LMT:

$20.61

MRK:

$3.58

PE Ratio

LMT:

25.41

MRK:

33.70

PS Ratio

LMT:

1.62

MRK:

4.59

PB Ratio

LMT:

16.16

MRK:

6.51

Total Revenue (TTM)

LMT:

$75.12B

MRK:

$65.59B

Gross Profit (TTM)

LMT:

$7.37B

MRK:

$49.79B

EBITDA (TTM)

LMT:

$8.09B

MRK:

$22.69B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

LMT vs. MRK — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LMT
LMT Risk / Return Rank: 5353
Overall Rank
LMT Sharpe Ratio Rank: 5858
Sharpe Ratio Rank
LMT Sortino Ratio Rank: 4949
Sortino Ratio Rank
LMT Omega Ratio Rank: 5050
Omega Ratio Rank
LMT Calmar Ratio Rank: 5353
Calmar Ratio Rank
LMT Martin Ratio Rank: 5454
Martin Ratio Rank

MRK
MRK Risk / Return Rank: 9090
Overall Rank
MRK Sharpe Ratio Rank: 9090
Sharpe Ratio Rank
MRK Sortino Ratio Rank: 9090
Sortino Ratio Rank
MRK Omega Ratio Rank: 8787
Omega Ratio Rank
MRK Calmar Ratio Rank: 9292
Calmar Ratio Rank
MRK Martin Ratio Rank: 9191
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

LMT vs. MRK - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Lockheed Martin Corporation (LMT) and Merck & Co., Inc. (MRK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


LMTMRKDifference
Sharpe ratioReturn per unit of total volatility

-1.79

Sortino ratioReturn per unit of downside risk

-2.45

Omega ratioGain probability vs. loss probability

1.11

1.39

-0.28

Calmar ratioReturn relative to maximum drawdown

0.50

5.42

-4.92

Martin ratioReturn relative to average drawdown

1.21

13.58

-12.38

LMT vs. MRK - Sharpe Ratio Comparison

The current LMT Sharpe Ratio is 0.47, which is lower than the MRK Sharpe Ratio of 2.26. The chart below compares the historical Sharpe Ratios of LMT and MRK, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


LMTMRKDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.47

2.26

-1.79

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.38

0.58

-0.20

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.47

0.51

-0.04

Sharpe Ratio (All Time)

Calculated using the full available price history

0.38

0.48

-0.11

Drawdowns

LMT vs. MRK - Drawdown Comparison

The maximum LMT drawdown since its inception was -79.29%, which is greater than MRK's maximum drawdown of -68.61%. Use the drawdown chart below to compare losses from any high point for LMT and MRK.


Loading charts...

Drawdown Indicators


LMTMRKDifference

Max Drawdown

Largest peak-to-trough decline

-79.29%

-68.61%

-10.68%

Max Drawdown (1Y)

Largest decline over 1 year

-25.15%

-11.37%

-13.78%

Max Drawdown (3Y)

Largest decline over 3 years

-31.79%

-43.44%

+11.65%

Max Drawdown (5Y)

Largest decline over 5 years

-31.79%

-43.44%

+11.65%

Max Drawdown (10Y)

Largest decline over 10 years

-36.67%

-43.44%

+6.77%

Current Drawdown

Current decline from peak

-22.09%

-3.64%

-18.45%

Average Drawdown

Average peak-to-trough decline

-26.84%

-18.84%

-8.00%

Ulcer Index

Depth and duration of drawdowns from previous peaks

10.41%

4.52%

+5.89%

Volatility

LMT vs. MRK - Volatility Comparison

The current volatility for Lockheed Martin Corporation (LMT) is 5.27%, while Merck & Co., Inc. (MRK) has a volatility of 9.45%. This indicates that LMT experiences smaller price fluctuations and is considered to be less risky than MRK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


LMTMRKDifference

Volatility (1M)

Calculated over the trailing 1-month period

5.27%

9.45%

-4.18%

Volatility (6M)

Calculated over the trailing 6-month period

19.58%

18.16%

+1.42%

Volatility (1Y)

Calculated over the trailing 1-year period

26.59%

27.28%

-0.69%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

22.87%

23.71%

-0.84%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

23.71%

22.96%

+0.75%

Dividends

LMT vs. MRK - Dividend Comparison

LMT's dividend yield for the trailing twelve months is around 2.61%, less than MRK's 2.75% yield.


PositionTTM20252024202320222021202020192018201720162015
LMT
Lockheed Martin Corporation
2.61%2.76%2.62%2.68%2.34%2.98%2.76%2.31%3.13%2.32%2.71%2.83%
MRK
Merck & Co., Inc.
2.75%3.12%3.14%2.72%2.52%3.41%3.03%2.48%2.60%3.36%3.14%3.43%

Financials

LMT vs. MRK - Financials Comparison

This section allows you to compare key financial metrics between Lockheed Martin Corporation and Merck & Co., Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


10.00B12.00B14.00B16.00B18.00B20.00B20222023202420252026
18.02B
16.29B
(LMT) Total Revenue
(MRK) Total Revenue
Values in USD except per share items

LMT vs. MRK - Profitability Comparison

The chart below illustrates the profitability comparison between Lockheed Martin Corporation and Merck & Co., Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%20222023202420252026
11.5%
81.9%
Portfolio components
LMT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Lockheed Martin Corporation reported a gross profit of 2.08B and revenue of 18.02B. Therefore, the gross margin over that period was 11.5%.

MRK - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Merck & Co., Inc. reported a gross profit of 13.34B and revenue of 16.29B. Therefore, the gross margin over that period was 81.9%.

LMT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Lockheed Martin Corporation reported an operating income of 2.06B and revenue of 18.02B, resulting in an operating margin of 11.5%.

MRK - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Merck & Co., Inc. reported an operating income of -1.88B and revenue of 16.29B, resulting in an operating margin of -11.6%.

LMT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Lockheed Martin Corporation reported a net income of 1.49B and revenue of 18.02B, resulting in a net margin of 8.3%.

MRK - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Merck & Co., Inc. reported a net income of -4.24B and revenue of 16.29B, resulting in a net margin of -26.0%.


Frequently Asked Questions


LMT and MRK have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

MRK has higher volatility (9.45%) compared to LMT (5.27%). In terms of maximum drawdown, LMT dropped -79.29% vs MRK's -68.61%.

MRK currently has the higher Sharpe Ratio (2.26 vs 0.47), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for LMT and MRK

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer